基于母亲危险因素的妊娠期糖尿病早孕期预测
该前瞻性队列研究纳入41587例单胎妊娠孕妇,其中4231例(10.2%)后续发生妊娠期糖尿病,基于母亲人口学特征和病史构建早孕期逻辑回归预测模型,模型区分度AUROC为0.757(95%CI 0.749-0.765),预测风险与实际发生率一致性良好。
要点
- 基于母亲年龄、体重、身高、种族及糖尿病家族史可早孕期预测妊娠期糖尿病。
- 经产且无妊娠期糖尿病史者,前次妊娠出生体重z评分对预测有贡献。
- 模型对胰岛素治疗者的检出率高于二甲双胍或单纯饮食治疗者。
核心结论
- 基于母亲危险因素可在早孕期评估妊娠期糖尿病风险。
研究设计与样本
- 前瞻性队列研究,纳入41587例单胎妊娠孕妇,孕11+0至13+6周,其中4231例(10.2%)后续发生妊娠期糖尿病。
- 采用逻辑回归模型预测妊娠期糖尿病,并进行五折交叉验证评估校准度和预测性能。
主要发现
- 在经产且有妊娠期糖尿病史者以及初产妇或经产无妊娠期糖尿病史者中,年龄、体重、身高、种族和糖尿病家族史均为显著预测因素。
- 在经产无妊娠期糖尿病史者中,前次妊娠出生体重z评分对预测有贡献。
- 预测风险与观察到的妊娠期糖尿病发生率一致性良好(截距0.000,95%CI -0.034至0.034;斜率1.000,95%CI 0.967至1.033)。
- AUROC为0.757(95%CI 0.749至0.765)。
- 筛查阳性率40%时,胰岛素治疗组、二甲双胍治疗组和单纯饮食治疗组的检出率分别为87.2%(95%CI 84.9至89.3)、80.0%(95%CI 77.8至82.0)和61.5%(95%CI 59.2至63.7)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and validate a new first-trimester model for the prediction of gestational diabetes mellitus (GDM) based on maternal demographic characteristics and elements of medical history. DESIGN: Prospective cohort study. SETTING: Inner-city hospital. POPULATION: 41 587 women with singleton pregnancies at 11+0-13+6 weeks' gestation, including 4231 (10.2%) who subsequently developed GDM. METHODS: Logistic regression model for GDM was developed and fivefold cross-validation was performed to assess the calibration and predictive performance of the model, assessed by the area under the receiver operating characteristic curve (AUROC) and detection rates (DRs) at different screen positive rates (SPRs). MAIN OUTCOME MEASURE: GDM. RESULTS: In both parous women with a previous history of GDM and nulliparous women or parous women with no history of GDM, significant contributors to the prediction of GDM were maternal age, weight, height, ethnicity and family history of diabetes mellitus. In parous women with no previous history of GDM, there was a contribution from the birthweight z-score of the previous pregnancy. There was good agreement between the predicted risk and observed incidence of GDM (intercept 0.000, 95% CI: -0.034, 0.034; slope 1.000, 95% CI: 0.967, 1.033). The AUROC curve was 0.757 (95% CI: 0.749, 0.765). The performance was higher for GDM treated with insulin versus metformin or diet alone. At SPR of 40%, the DR of the insulin, metformin and diet alone group was 87.2% (95% CI: 84.9, 89.3), 80.0% (77.8, 82.0) and 61.5% (59.2, 63.7), respectively. CONCLUSION: Assessment of risk for GDM can be achieved in the first trimester based on maternal risk factors.
引用
- Syngelaki A, Wright A, Gomez Fernandez C, et al. First-Trimester Prediction of Gestational Diabetes Mellitus Based on Maternal Risk Factors. BJOG. 2025. PMID: 40000426. doi:10.1111/1471-0528.18110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。